CD24 and neoplasm: A large number of subpopulations with enhanced tumor initiating capacity have been identified, especially several markers, including CD24, CD44, CD117, CD133, ABCG, ESA and ALDH, which are widely used in the literature to identify and investigate human epithelial cancer stem cells.